Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
14 March 2016Website:
http://www.mydario.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 03 Jul 2024 17:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
DRIO Latest News
DarioHealth Corp. (DRIO) reported a quarterly loss of $0.20 per share, beating the Zacks Consensus Estimate of a loss of $0.59. This is a decrease from earnings of $0.45 per share in the same quarter last year.
DarioHealth has experienced a disappointing year with stalled revenue growth and a decline in new customer wins. However, H2/23 and FY24 are expected to bring improved financials, including revenue growth, expanded gross margins, and declining operating expenses. The company's competitive advantages include a customer-friendly platform, a multi-condition platform, and partnerships with important industry players.
DarioHealth Co. NASDAQ: DRIO is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic diseases. The mobile app manages five common comorbidity conditions, including diabetes, weight loss, hypertension, musculoskeletal and behavioral health, across six domains: timing, tone, channel, content, frequency and intervention.
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Chuck Padala - Managing Director, Investor Relations Erez Raphael - Chief Executive Officer Rick Anderson - President Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen Rahul Rakhit - LifeSci Capital Benjamin Haynor - Alliance Global Partners David Grossman - Stifel Financial Operator Good morning, and welcome to the DarioHealth First Quarter 2023 Results Call. All participants are in a listen only mode [Operator Instructions] After today's presentation, there will be opportunity to ask questions.
What type of business is DarioHealth?
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
What sector is DarioHealth in?
DarioHealth is in the Healthcare sector
What industry is DarioHealth in?
DarioHealth is in the Health Information Services industry
What country is DarioHealth from?
DarioHealth is headquartered in United States
When did DarioHealth go public?
DarioHealth initial public offering (IPO) was on 14 March 2016
What is DarioHealth website?
https://www.mydario.com
Is DarioHealth in the S&P 500?
No, DarioHealth is not included in the S&P 500 index
Is DarioHealth in the NASDAQ 100?
No, DarioHealth is not included in the NASDAQ 100 index
Is DarioHealth in the Dow Jones?
No, DarioHealth is not included in the Dow Jones index
When does DarioHealth report earnings?
The next expected earnings date for DarioHealth is 09 August 2024